Sachdev Amit

Average Profitability
5.21%
Insider Buys Quantity
1
Insider Buys Sum
$24,720.00
Insider Sells Quantity
103
Insider Sells Sum
$165.66M

Insider Activity of Sachdev Amit

According to the SEC Form 4 filings, Sachdev Amit, being in a position of

  1. EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 13703 shares for $5.78M,
    over all time since 2007-11-07, has bought 1000 shares for $24,720, and sold 1283024 shares for $165.66M.

The largest purchase of all time was on 2007-11-07 and amounted to 1000 shares of Vertex Pharmaceuticals Incorporated for $24,720.

The largest sale of all time was on 2014-09-30 and amounted to 172000 shares of Vertex Pharmaceuticals Incorporated for $19.38M.

Biography of Sachdev Amit

No biography is available at this moment.

2024-05-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
32
<0.0001%
$430.93$13,790+8.71%
2024-02-26SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
3,004
0.0011%
$425.70$1.28M+7.25%
2024-02-21SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
3,191
0.0012%
$421.77$1.35M+10.5%
2024-02-20SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
4,254
0.0016%
$420.79$1.79M+10.04%
2024-02-12SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
3,222
0.0013%
$420.24$1.35M+9.78%
2023-11-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP Chief Patient & Ext Af Off
35
<0.0001%
$369.92$12,947+23.75%
2023-08-10SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
10,031
0.0039%
$350.00$3.51M+17.33%
2021-11-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
51
<0.0001%
$187.19$9,547+44.25%
2021-05-17SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
45
<0.0001%
$216.35$9,736-4.41%
2021-04-27SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
3,884
0.0015%
$216.06$839,193-4.05%
2021-02-25SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
3,586
0.0014%
$213.42$765,307-2.9%
2021-02-18SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
9,264
0.0036%
$211.83$1.96M-1.39%
2021-02-11SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
4,460
0.0017%
$210.55$939,068-1.76%
2020-11-16SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
42
<0.0001%
$223.53$9,388-6.17%
2020-08-03SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
1,941
0.0007%
$278.28$540,137-22.49%
2020-05-15SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
58
<0.0001%
$284.41$16,496-19.72%
2020-05-11SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
10,665
0.0041%
$282.61$3.01M-18.47%
2020-05-06SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
669
0.0003%
$275.28$184,162-13.36%
2020-05-05SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
13,356
0.0051%
$270.01$3.61M-13.89%
2020-05-04SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Patient Officer
43,752
0.0167%
$262.28$11.48M-11.37%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.